 Quest Diagnostics Inc. DGX, -1.08 offered guidance for the fourth quarter and full year on Wednesday that exceeded Wall Street estimates, driven by demand for COVID-19 testing services. The company is now expecting per-share earnings of 3.12 and adjusted EPS of 3.33, ahead of the 3.07 FactSet consensus. 